Latest News
☰
×
Home
Education
Chronic Kidney Disease and Acid
Chronic Kidney Disease and Anemia
Chronic Kidney Disease and Diabetes
Chronic Kidney Disease and Healthy Bones
Chronic Kidney Disease and Hypertension
Chronic Kidney Disease and Nutrition
Chronic Kidney Disease and Protein
Chronic Kidney Disease and Vitamin D
RSH Smoking Guide
Top 10 Tips for Chronic Kidney Disease Patients
Services
About Us
Contact Us
Blog
By
Galen Care Partners
on Monday, 18 September 2017
Category:
Galen Care Partners News
Immunotherapy Superior to Sunitinib for Front-Line mRCC Treatment
Checkpoint inhibitor combination of nivolumab plus ipilimumab improved progression-free and overall survival compared with sunitinib.
Original link
Leave Comments